Management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy

Journal of Endourology
Vincent G BirdVictoria Y Bird

Abstract

Laparoscopic-guided radiofrequency ablation (LRFA) has been introduced as a minimally invasive nephron-sparing management option for renal tumors. Many patients who desire treatment present with multiple comorbidities, which poses a therapeutic challenge. Our purpose is to determine if multipass LRFA is comparable, in terms of surgical risk and immediate postoperative outcomes, to laparoscopic partial nephrectomy (LPN). A retrospective study identified 36 and 33 patients who underwent LRFA and LPN, respectively. Perioperative demographic data, tumor characteristics, and follow-up data were evaluated. Statistical analysis was performed using the Student t test and chi-square analysis. Age, American Society of Anesthesiology score, and Charlson Comorbidity Index were significantly higher in the LRFA group than the LPN group (P < 0.001). Average tumor size was 2.8 cm and 3.1 cm for the LRFA and LPN groups, respectively. There were no significant differences in change between the preoperative and postoperative creatinine/glomerular filtration rate values or perioperative complication rates for the groups. Estimated blood loss and length of stay were significantly lower for the LRFA group than the LPN group (P < 0.05). Follow-up ran...Continue Reading

References

Mar 1, 1989·Radiology·S J SmithB N Raghavendra
Aug 1, 1995·Urology·A C Novick
Dec 1, 1993·Journal of Endourology·H N WinfieldR V Clayman
Dec 1, 2000·The Urologic Clinics of North America·J J RassweilerK Jeschke
May 24, 2001·Current Opinion in Urology·H Van PoppelL Baert
Nov 17, 2001·Urology·K JeschkeK Henning
Jun 11, 2003·The Journal of Urology·Inderbir S GillAndrew C Novick
Apr 13, 2004·The Journal of Urology·J J HwangB J Wood
Jun 18, 2004·The Journal of Urology·Edward D MatsumotoJeffrey A Cadeddu
Mar 19, 2005·European Urology·Firas AbukoraGünter Janetschek
Apr 12, 2005·The Journal of Urology·David S FinleyRalph V Clayman
Jul 12, 2005·The Journal of Urology·Ioannis M VarkarakisStephen B Solomon
Apr 8, 2006·The Journal of Urology·Amr F FerganyAndrew C Novick
Jul 11, 2006·The Urologic Clinics of North America·J Kyle AndersonJeffrey A Cadeddu
Aug 15, 2006·Journal of Endourology·Sangtae ParkJeffrey A Cadeddu
Aug 15, 2006·Current Opinion in Urology·C Charles Wen, Stephen Y Nakada
Oct 31, 2006·European Urology·Vladimir MouravievThomas J Polascik
Nov 7, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Marek SalagierskiMarek Sosnowski
Nov 11, 2006·Urology·Paul S UribeAndrew C Peterson
Apr 18, 2007·BJU International·H Christoph KlinglerMartin Susani
Jun 19, 2007·Cardiovascular and Interventional Radiology·David J BreenChristopher J Smart
Jun 19, 2007·The Journal of Urology·Inderbir S GillAndrew C Novick

❮ Previous
Next ❯

Citations

Jan 15, 2011·Current Urology Reports·Scott M CastleRaymond J Leveillee
Feb 4, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J-A LongJ-J Patard
Dec 7, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J-J PatardUNKNOWN Oncology Committee of the French Association of Urology (CCAFU)
Jan 16, 2010·Journal of Endourology·Charles MooreRaymond Leveillee
Apr 8, 2010·Journal of Endourology·Steven M Lucas, Jeffrey A Cadeddu
Apr 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Bellmunt, J Dutcher
Dec 1, 2010·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Branden G Duffey, J Kyle Anderson
Feb 1, 2014·Cardiovascular and Interventional Radiology·K KatsanosA Adam
Sep 3, 2014·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy·Cheng-Qiang MoShao-Peng Qiu
Nov 3, 2015·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Baoan HongYong Yang
Sep 29, 2015·Journal of Endourology·Patricia J ZondervanM Pilar Laguna
Aug 7, 2010·Journal of Vascular and Interventional Radiology : JVIR·Adeep B ThumarDaniel B Brown
Mar 13, 2012·BJU International·Catherine R HarrisMaxwell V Meng
Jul 24, 2015·AJR. American Journal of Roentgenology·Luke J Higgins, Kelvin Hong
Oct 20, 2011·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Michael A GorinVincent G Bird
Mar 6, 2019·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Karli PeñaNelson Salas
Apr 24, 2013·Nature Reviews. Urology·Arturo CastroRaymond J Leveillee
Oct 28, 2011·Expert Review of Medical Devices·Nelson SalasRaymond J Leveillee
Jul 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Bellmunt, J Dutcher
Feb 4, 2010·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.